Mergers & Acquisitions Mergers & Acquisitions

Non-horizontal theories of harm an enforcement priority in tech-healthcare deals, senior US FTC official says

By Flavia Fortes
  • 24 May 2023 23:19
  • 24 May 2023 23:19
The focus on non-horizontal theories of harm in deals between technology and healthcare companies will be prevalent as convergence between the two sectors grows, a senior US Federal Trade Commission official said.

“This convergence is likely to lead the agencies to pay particular attention to non-horizontal theories of harm and, as a result,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Flavia Fortes

Global Head of Mergers

Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.

Discover MLex

Stay on top of global regulatory developments

Latest News